PetMed Express to Acquire PetCareRx, Deal Expected to Close in Early 2023
January 31, 2023
Trending News 🌥️
PETMED ($NASDAQ:PETS): PetMed Express Inc. (NASDAQ: PETS) is a leading online supplier of pet medications, food, and supplies. Now, the company has announced that it will be acquiring PetCareRx, a leading online supplier of pet medications and products, in a deal that is expected to close in early 2023. The financial terms of the deal have not yet been revealed, but the acquisition is expected to significantly expand PetMed Express’s product offerings and customer reach. PetCareRx has a strong presence in the pet care industry, with a loyal customer base and a broad selection of products that are tailored to the needs of pet owners. This will be a great addition to PetMed Express’s offerings and will enable them to better serve their current customers and reach more pet owners in the future. The acquisition is also expected to bring significant cost-savings to PetMed Express, as they will be able to benefit from PetCareRx’s well-established purchasing relationships with suppliers and manufacturers.
This will enable PetMed Express to offer their customers even greater value while maintaining their commitment to providing quality products at competitive prices. The acquisition of PetCareRx is an exciting development for PetMed Express and its customers. The additional product offerings and cost savings that it brings are sure to benefit the company and its customers in the long run. With the deal expected to close in early 2023, pet owners can look forward to even more value and convenience when shopping for their pets at PetMed Express.
Price History
On Tuesday, PETMED EXPRESS announced that it has agreed to acquire PetCareRx, a leading online pet pharmacy. The deal is expected to close in early 2023. The news was met with positive media exposure and a significant jump in PETMED EXPRESS’ stock price. On Tuesday, the stock opened at $19.1 and closed at $19.8, up by 3.7% from its prior closing price of 19.1. The acquisition of PetCareRx allows PETMED EXPRESS to expand its product offerings and customer base. With the addition of PetCareRx, PETMED EXPRESS will now be able to offer a variety of pet care products and services, including flea and tick control, pet supplements, pet insurance, and pet health plans. In addition to expanding its product offerings, the acquisition of PetCareRx will also allow PETMED EXPRESS to increase its market share in the online pet pharmacy sector.
It will also provide PETMED EXPRESS with access to a large customer base that is already familiar with the PetCareRx brand. The deal is expected to bring many synergistic benefits to both companies. PETMED EXPRESS will be able to leverage PetCareRx’s expertise in the online pet pharmacy sector, while PetCareRx will be able to benefit from PETMED EXPRESS’ financial strength and resources. Overall, the acquisition of PetCareRx by PETMED EXPRESS appears to be a smart move that will benefit both companies. The deal is expected to close in early 2023, and it is likely that the positive media exposure will continue to fuel the growth of PETMED EXPRESS’ stock price. Live Quote…
About the Company
Income Snapshot
Below shows the total revenue, net income and net margin for Petmed Express. More…
| Total Revenues | Net Income | Net Margin |
| 262.3 | 15.68 | 6.0% |
Cash Flow Snapshot
Below shows the cash from operations, investing and financing for Petmed Express. More…
| Operations | Investing | Financing |
| 22.53 | -8.12 | -24.43 |
Balance Sheet Snapshot
Below shows the total assets, liabilities and book value per share for Petmed Express. More…
| Total Assets | Total Liabilities | Book Value Per Share |
| 169.26 | 31.11 | 6.55 |
Key Ratios Snapshot
Some of the financial key ratios for Petmed Express are shown below. More…
| 3Y Rev Growth | 3Y Operating Profit Growth | Operating Margin |
| -1.5% | -16.2% | 7.1% |
| FCF Margin | ROE | ROA |
| 7.4% | 8.4% | 6.9% |
VI Analysis
For any investor, a company’s fundamental performance and health is of primary importance for gauging its long-term potential. For this reason, the VI App has been designed to provide users with a concise and comprehensive assessment of a given company’s financial and business aspects. In the case of PETMED EXPRESS, the VI Risk Rating assigns it a medium risk rating, indicating that it may present a certain degree of risk to investors. This rating is based on the company’s financial data and performance, which are taken into account by the app’s proprietary algorithms. The app also detects potential risk warnings in the company’s income and balance sheets. These risk warnings can provide users with important information regarding potential areas of caution before investing. To access this information, users must register with the VI App. Overall, the VI App provides users with an easy way to assess the long-term potential of a company such as PETMED EXPRESS, allowing them to make more informed decisions about their investments. More…
VI Peers
PetMed Express Inc is one of the largest online pet pharmacies in the United States. The company offers a wide range of pet medications, supplies, and products at competitive prices. PetMed Express also offers a wide variety of services, including prescription refill reminders, online pet health information, and a pet health hotline. The company’s main competitors are Oriola Corp, Trxade Health Inc, Yunnan Jianzhijia Health-Chain Co Ltd.
– Oriola Corp ($LTS:0NER)
Oriola Corporation is a Finnish company that provides branded pharmaceuticals and services to the pharmaceutical industry and retail pharmacies. The company has a market capitalization of €330.77 million and a return on equity of 7.73%. Oriola Corporation is a leading provider of branded pharmaceuticals and services to the pharmaceutical industry and retail pharmacies. The company offers a wide range of products and services, including branded pharmaceuticals, generic pharmaceuticals, over-the-counter (OTC) products, medical devices, and services.
– Trxade Health Inc ($NASDAQ:MEDS)
Trxade Health Inc is a healthcare company that focuses on providing services and products to the healthcare industry. The company has a market cap of 8.16M as of 2022 and a Return on Equity of -110.47%. Trxade Health Inc’s main products and services include healthcare software and services, medical supplies, and pharmaceuticals. The company operates in the United States and Canada.
– Yunnan Jianzhijia Health-Chain Co Ltd ($SHSE:605266)
Yunnan Jianzhijia Health-Chain Co Ltd is a Chinese company that focuses on the development and application of health-related big data technology. The company’s products and services include a health information platform, a health data application platform, and a health management platform. As of 2022, Yunnan Jianzhijia Health-Chain Co Ltd has a market cap of 5.46B and a Return on Equity of 11.7%.
Summary
PetMed Express (PETX) has recently announced its plans to acquire PetCareRx, a pet medication and supply company, in a deal expected to close in early 2023. Following the announcement, the company’s stock price saw an increase, indicating that investors have responded positively to the news. Analysts believe that the combination of PETX and PetCareRx’s expertise in pet medication, resources, and customer base will create a strong provider of pet health products. The acquisition is expected to benefit both companies in terms of increased economies of scale, as well as enhanced capabilities for product and services offerings.
The deal is also likely to result in reduced cost structure and improved customer experience. Overall, the acquisition looks promising for investors, and could be a great opportunity for those looking to gain exposure to the pet care industry.
Related Posts
Recent Posts
Investing Everyone Can Do.
Investing shouldn’t be exclusive to a select few. We believe everyone should have the opportunity to grow their wealth. That’s why our app is designed to be accessible and user-friendly, even for beginners.
